“…It is critical for correct deposition of elastin, mediates cell-matrix communication and regulates organogenesis, fibrogenesis, vascular remodelling and tumour metastasis (Zheng et al , 2007; Yanagisawa et al , 2009). Three homozygous missense mutations (p.C217R, p.S227P and p.R284X) in FBLN5 have been reported in patients with an autosomal recessive, generalized form of the connective tissue disorder cutis laxa (Loeys et al , 2002; Elahi et al , 2006; Hu et al , 2006; Claus et al , 2008; Nascimento et al , 2010), and a heterozygous in-frame tandem duplication of exons 5–8 in FBLN5 was seen in a sporadic patient with cutis laxa suggesting that the large protein acts in a dominant negative way (Markova et al , 2003). Ten distinct, heterozygous FBLN5 missense mutations have been associated with age-related macular degeneration, the leading cause of severe visual loss among patients older than 50 years in the western world (Stone et al , 2004; Lotery et al , 2006; Jones et al , 2009, 2010; Schneider et al , 2010).…”